Tobacco Documents Online

Set of charts detailing the effects of filter, porosity, puff frequency, and blends on smoke delivery.

Procedure for actions to be taken when a brand exceeds the outside control limits for FTC delivered tar. Departments assigned to assess cause and scope of problem, course of action, production and testing of samples, specification changes, and production and implementation of changes. Changes may consist of altered filter RTD (resistance to draw) for small adjustments in FTC tar, paper changes for larger FTC tar deliveries, and dilution changes (for those brands already having dilution). Changes in RTD and dilution to require approval of company management.

Lays out the goals and objectives of a research study on human smoking habits. Summarizes past findings that nicotine yield "depends more on the smoker himself than on the cigarette he smokes" and speculates that within a given brand the need for nicotine "is quite different between individuals...leading to a wide spectrum of the actual parameters." Claims that smoking provides a "short-term regulated system" for nicotine delivery "settled by the smoker at each puff, more or less independently of the available quantity." Determines a need to pursue the question of whether specific products are suited to specific smokers, through investigation of smoking behavior of "a few well selected smokers". Concludes with a list of objectives to achieve the stated goal.

Public statement by B&W addressing Barclay controversy and use of Actron filter. Claims that the Actron filter improves taste delivery through unique smoke swirl impacting a large number of taste sensors in the mouth simultaneously. Discusses deficiencies of FTC machine testing system, and argues against singling out Barclay cigarettes for exclusion from this test methodology given the many modes of compensation possible among brands for human smokers.

Chart showing smoke pH for selected set of B&W brands vs FTC smoke nicotine. Estimated percent of free nicotine in B&W cigarettes at an average smoke pH of 4.8: 0.085% unionized (free) nicotine, 99.915% ionized (bound). Average pH measurements range from 4.5 to 5.3 (for Burley straight grade.)

Description of proposed method for experimental smoke pH measurement. Whole smoke measurement in an aqueous solution with no Cambridge pad and no cold trap but good TPM recovery. Smoke pH value will reflects contribution of both vapor-phase and particulate-phase smoke. Initial pH measurements range between 4.5 and 5.5.

Written by a consultant to the U.S. Consumer Product Safety Commission. Discusses the details of the FTC smoking machine tests and compares them to the CORESTA method. Discussion follows on materials and methods of testing, samples, cost, and results. The document recommends using the FTC method in determining the particulate deliveries of low-yield cigarettes because the apparatus and methodology are flexible and can more closely conform to how smokers actually smoke.

Lists questions and answers regarding ingredients added to cigarettes. Discusses types of ingredients such as casing materials and humectants. Defends the use of ingredients in the manufacture of cigarettes. Makes case for why "identity of ingredients" has not been made available to the public. Indicates the industry will "cooperate with the Department of Health and Human Services in its review of the [ingredient] list." Discusses testing of ingredients and addresses concerns about their health effects.

Catalogues the status of 32 Philip Morris Cos., Inc. [PM] and Philip Morris Cos. International, Inc. [PMI] product development projects. Reports experimental low sidestream [SS] cigarettes demonstrate a 50 plus percent reduction in smoke visibility, Marlboro modifications provide favorable subjectives and concentric filter design findings are being summarized. Lists international projects underway, compiles results of competitive testing and summarizes the current status of PM cigarette design.

Outlines Philip Morris' [PM] five year research and development strategic goals, operational plans and manufacturing recommendations. Compiles and analyzes competitor's strengths and weaknesses, cites serious shortfalls due to decreasing cigarette sales and increasing costs associated with regulatory compliance. Attributes some of these declines to competition and says the pharmaceutical companies marketing of tobacco cessation products and the anti-smoking movement further impacts market share. States reducing manufacturing costs and maximizing existing brand sales are short term goals and indicates consumer perceptions of branding and product quality are key elements to success. Lists production concepts for leaf selection, tobacco processing, use of reconstituted blends and decreases in cigarette weight. States a major shift to increased use of expanded tobacco, reconstituted leaf and cast sheet tobacco is in play and says environmental regulations restrict and "impact the design and marketing of our products." Lists strategies to: reduce the number of ingredients in flavor formulations, continue to decrease sidestream [SS] smoke, reduce Carbon monoxide [CO] and overcome consumer health concerns and the technical problems of cigarette design and production.